Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
Seeking Alpha / 6 hours ago 3 Views
Seeking Alpha / 6 hours ago 3 Views
Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms
Comments